# Examinations of Tissue From Ablated Malignant Liver Metastases as Predictors of Outcome

> **NCT01494324** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 150 (actual)

## Conditions studied

- Liver Cancer

## Interventions

- **OTHER:** CT guided percutaneous ablation

## Key facts

- **NCT ID:** NCT01494324
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2009-10-27
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2026-01-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01494324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01494324, "Examinations of Tissue From Ablated Malignant Liver Metastases as Predictors of Outcome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01494324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*